CLSI X03R

Implementing a Needlestick and Sharps Injury Prevention Program in the Clinical Laboratory, X03-R

Clinical and Laboratory Standards Institute, 03/01/2002

Publisher: CLSI

File Format: PDF

$90.00$180.00

Published:01/03/2002

Pages:35

File Size:1 file , 450 KB

Note:This product is unavailable in Russia, Belarus

This document provides guidance for implementing safer medical devices that reduce or eliminate sharps injuries to laboratory personnel.

Assays of von Willebrand Factor Antigen and Ristocetin Cofactor Activity; Approved Guideline, H51-A

$116.00 $233.68

Assessment of Laboratory Tests When Proficiency Testing is Not Available; Approved Guideline, GP29-A

$103.00 $207.62

Gas Chromatography/Mass Spectrometry (GC/MS) Confirmation of Drugs; Approved Guideline, 43-A

$110.00 $221.61

Point-of-Care Blood Glucose Testing in Acute and Chronic Care Facilities; Approved Guideline, C30-A2

$148.00 $297.17